Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Evolved Machines Enters Into License Agreement with Nanosys and Launches Development of DNA-activated Carbon Nanotube Transistor Sensors

Abstract:
Evolved Machines, Inc. and Nanosys Inc. today announced that Evolved Machines has entered into a sublicense agreement with Nanosys for a portfolio of patents and patent applications related to the use of nanotubes and nanowires for artificial olfaction and chemical sensing.

Evolved Machines Enters Into License Agreement with Nanosys and Launches Development of DNA-activated Carbon Nanotube Transistor Sensors

PALO ALTO, CA | Posted on December 3rd, 2008

The core intellectual property involves a wide range of applications in nanotechnology, nanomaterials and the use of nanotube and nanowire-based field effect transistors (FET's) as biosensors. Nanosys owns an extensive portfolio of IP around multiple aspects of nanotechnology including basic nanowire compositions, nanowire synthesis and the use of nanowires and other nanostructures for many applications.

Under terms of the agreement, Evolved Machines has secured or has obtained options to secure a variety of exclusive, worldwide rights among which are the use of DNA-functionalized nanowire or nanotube-based sensor arrays for the detection and/or identification of an analyte or analytes in the gas and/or liquid phase.

Evolved Machines, in partnership with its affiliate iSense, LLC, is developing nanotube-based field effect transistors (FETS) functionalized by DNA as highly sensitive sensors across a very wide range of targets. "The DNA sequence-dependent nature of binding affinity for these devices enables highly diverse analyte discrimination, while the nanotube transistor imparts great sensitivity. Further, this class of sensor is completely reversible across a wide range of analytes, allowing repeated use and enabling the first devices capable of remote autonomous multi-analyte sensing," according to Dr. Paul A. Rhodes, Evolved Machines CEO.

Working in partnership with its affiliate, iSense, Evolved Machines is developing a wide range of immediate high-value applications ranging from airport, port and transit screening, to first responder domestic and military hand-held sets, to medical diagnosis, to autonomous 24/7 monitoring of the water supply and of containers on-board ship.

####

About Evolved Machines, Inc.
Evolved Machines, Inc. develops technology for sensory systems based on highly neural sensory signal processing, reverse-engineering circuitry in the brain to enable a new class of self-wiring devices that perform in the complexities of real-world environments, for both artificial olfaction and visual object recognition.

About Nanosys, Inc.

Nanosys, Inc. is a leader in the development of nanotechnology enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 600 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense.

Additional information on Nanosys can be found at www.nanosysinc.com.

About iSense, LLC

iSense, LLC manufactures broad spectrum chemical sensing devices enabling rapid identification across thousands of analytes. These devices incorporate Evolved Machines' intelligent neural pattern recognitions algorithms to enable performance under real-world conditions. Additional information on iSense can be found at www.isensesytems.com.

For more information, please click here

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Sensors

Innovative sensing platform unlocks ultrahigh sensitivity in conventional sensors: Lan Yang and her team have developed new plug-and-play hardware to dramatically enhance the sensitivity of optical sensors April 5th, 2024

$900,000 awarded to optimize graphene energy harvesting devices: The WoodNext Foundation's commitment to U of A physicist Paul Thibado will be used to develop sensor systems compatible with six different power sources January 12th, 2024

A color-based sensor to emulate skin's sensitivity: In a step toward more autonomous soft robots and wearable technologies, EPFL researchers have created a device that uses color to simultaneously sense multiple mechanical and temperature stimuli December 8th, 2023

New tools will help study quantum chemistry aboard the International Space Station: Rochester Professor Nicholas Bigelow helped develop experiments conducted at NASA’s Cold Atom Lab to probe the fundamental nature of the world around us November 17th, 2023

Announcements

New organic molecule shatters phosphorescence efficiency records and paves way for rare metal-free applications July 5th, 2024

Single atoms show their true color July 5th, 2024

New method cracked for high-capacity, secure quantum communication July 5th, 2024

Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project